NRx Pharmaceuticals, Inc.
NRXP
$2.75
$0.124.56%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -47.55% | 284.48% | -12.33% | -13.28% | 43.90% |
Total Receivables | -- | -- | -- | 0.00% | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -9.46% | -64.93% | 80.20% | -25.16% | 100.37% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 9.81% | -15.90% | -2.83% | 2.17% | -12.72% |
Total Current Assets | -36.74% | 119.75% | -19.58% | -15.86% | 45.80% |
|
|||||
Total Current Assets | -36.74% | 119.75% | -19.58% | -15.86% | 45.80% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -28.14% | -4.30% | -1.97% | -7.29% | -12.93% |
Total Assets | -36.26% | 107.89% | -18.18% | -15.24% | 38.97% |
|
|||||
Total Accounts Payable | -15.80% | 4.38% | -15.13% | -2.97% | -19.95% |
Total Accrued Expenses | 9.35% | -67.75% | 194.50% | -19.41% | 23.64% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 17.35% | 573.92% | -59.15% | -60.14% | 12.86% |
Total Finance Division Other Current Liabilities | 44.03% | -8.92% | 141.70% | 72.59% | 14,646.15% |
Total Other Current Liabilities | 44.03% | -8.92% | 141.70% | 72.59% | 14,646.15% |
Total Current Liabilities | 23.52% | 49.80% | 7.70% | -14.19% | 25.44% |
|
|||||
Total Current Liabilities | 23.52% | 49.80% | 7.70% | -14.19% | 25.44% |
Long-Term Debt | -- | -- | 67.87% | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 23.52% | 21.87% | 15.42% | -1.57% | 25.44% |
|
|||||
Common Stock & APIC | 2.76% | 1.40% | 1.87% | 0.48% | 1.87% |
Retained Earnings | -6.20% | -1.98% | -3.37% | -0.61% | -3.04% |
Treasury Stock & Other | -- | -- | -- | -- | 0.00% |
Total Common Equity | -41.55% | -8.35% | -23.38% | -2.34% | -22.05% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -41.55% | -8.35% | -23.38% | -2.34% | -22.05% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -41.55% | -8.35% | -23.38% | -2.34% | -22.05% |
|